-
-
Anti-GD2 Reference Antibody (dinutuximab),, 50 микрограмм
-
Anti-GCGR Reference Antibody (volagidemab),, 50 микрограмм
-
Anti-GAD65 Reference Antibody (U.Washington patent anti-GAD65),, 50 микрограмм
-
Anti-GCGR Reference Antibody (crotedumab),, 50 микрограмм
-
Anti-FZD7 Reference Antibody (U.Toronto patent anti-FZD7),, 50 микрограмм
-
Anti-FZD Reference Antibody (vantictumab),, 50 микрограмм
-
Anti-FZD10 Reference Antibody (tabituximab),, 50 микрограмм
-
Anti-Fucosyl GM1 Reference Antibody (BMS-986012),, 50 микрограмм
-
Anti-FOLR1 Reference Antibody (farletuzumab),, 50 микрограмм
-
Anti-FOLR1 Reference Antibody (mirvetuximab),, 50 микрограмм
-
Anti-FOLR1 Reference Antibody (Dompe patent anti-FOLR1),, 50 микрограмм
стр.: